Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 9, 1998, Pages 1055-1063

  Puddu, Patrizia ^a   Borghi, Paola ^a   Gessani, Sandra ^a   Valenti, Piera ^b   Belardelli, Filippo ^a   Seganti, Lucilla ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiviral agents; Chelating agent; Glycoprotein; HIV; Lactoferrin

Indexed keywords

FERRIC ION; GLYCOPROTEIN; LACTOFERRIN; MANGANESE; METAL ION; ZINC ION;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIRUS INHIBITION;

ADSORPTION; ANIMALS; ANTI-HIV AGENTS; APOPROTEINS; CATTLE; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HIV INFECTIONS; HIV-1; HUMANS; LACTOFERRIN; METALS; VIRUS REPLICATION;

BOVINAE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 0031762646     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00066-1     Document Type: Article

References (46)

1. E.N. Baker, B.F. Anderson, H.M. Baker, C.L. Day, M. Haridas, G.E. Norris, S.V. Rumball, C.A. Smith, D.H. Thomas, Three-dimensional structure of lactoferrin in various functional states, Adv. Exp. Med. Biol. 357 (1994) 1-12.
2. B.G. Johansson, Isolation of an iron containing red protein from human milk, Acta Chem. Scand. 14 (1960) 10-12.
3. P.F. Levay, M. ViIjoen, Lactoferrin: a general review, Haematologica 80 (1995) 252-267.
4. P.L. Masson, J.F. Heremans, C.H. Dive, An iron-binding protein common to many external secretions, Clin. Chim. Acta 14 (1966) 735-739.
5. P.L. Masson, J.F. Heremans, E. Schonne, Lactoferrin, an iron-binding protein in neutrophilic leukocytes, J. Exp. Med. 130 (1969) 643-658.
6. J. Montreuil, S. Mullet, Isolement d'une lactosidérophiline du lait de Femme, C.R. Acad. Sci. Paris 250 (1960) 1736-1737.
7. J. Montreuil, J. Tonnelat, S. Mullet, Préparation et propriétés de la lactosidérophiline (lactotransferrine du lait de Femme), Biochim. Biophys. Acta 45 (1960) 413-421.
8. T.J. Guttenberg, B. Haneberg, T. Jorgensen, The latency of serum acute proteins meningococcal septicaemia with special emphasis on lactoferrin, Clin. Chim. Acta 136 (1984) 173-178.
9. J.A. Lash, T.D. Coates, J. Lafuze, R.L. Bachner, L.A. Boxer, Plasma lactoferrin reflects granulocyte activation in vivo, Blood 61 (1983) 885-888.
10. J.H. Nuijens, J.J. Abbink, Y.T. Wachtfogel, R.W. Cohnan, A.J. Eerenberg, D. Dors, A.J. Kamp, R.J. Strack van Schijndel, L.G. Thijs, C.E. Hack, Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis, J. Lab. Clin. Med. 119 (1992) 159-168.
11. S.E. Comerie-Smith, J. Nunez, M. Hosmer, R.L. Fards, Tear lactoferrin and ocular bacterial flora in HIV positive patients, Adv. Exp. Med. Biol. 350 (1994) 339-344.
12. M.C. Defer, B. Dugas, O. Picard, C. Damais, Impairment of circulating lactoferrin in HIV-infection, Cell. Mol. Biol. 41 (1995) 417-421.
13. R.R. Arnold, M. Brewer, J.J. Gauthier, Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms, Infect. Immun. 28 (1980) 893-898.
14. J.H. Brock, Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant, Archiv. Dis. Child. 55 (1980) 417-421.
15. R.T. Ellison III., T.J. Giehl, F.M. LaForce, Damage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin, Infect. Immun. 56 (1988) 2774-2781.
16. P. Visca, C. Dalmastri, D. Verzili, G. Antonini, E. Chiancone, P. Valenti, Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity, Med. Microbiol. Immun. 179 (1990) 323-333.
17. A.R. Kishore, J. Erdei, S. Kalfas, A. Forsgren, A.S. Naidu, Detection of bacterial interaction with lactoferrin by an enzyme-linked ligand binding assay (ELBA), J. Med. Microbiol. 37 (1992) 341-345.
18. W. Bellamy, M. Takase, K. Yamauchi, V. Wakabayashi, K. Kawase, M. Tomita, Identification of the bactericidal domain of lactoferrin, Biochim. Biophys. Acta 1121 (1991) 130-136.
19. 2+, Am. J. Physiol. 257 (1989) G930-G934.
20. D. Legrand, J. Mazurier, A. Elass, E. Rochard, G. Vergoten, P. Maes, J. Montreuil, G. Spik, Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactoferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin, Biochemistry 31 (1992) 9243-9251.
21. A.I. Maneva, L.M. Sirakov, V. Manev, Lactoferrin binding to neutrophilic polymorphonuclear leucocytes, Int. J. Biochem. 15 (1983) 981-984.
22. E. Rochard, D. Legrand, J. Mazurier, J. Montreuil, G. Spik, The N-terminal domain I of human lactoferrin binds specifically to phytohemagglutinin stimulated peripheral blood human lymphocyte receptors, FEBS Lett. 255 (1989) 201-204.
23. 4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells, Biochem. J. 327 (1997) 841-846.
24. Z.S. Ji, R.W. Mahley, Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG, Arterioscl. Throm. 14 (1994) 2025-2031.
25. D.M. Mann, E. Romm, V. Migliorini, Delineation of the glycosaminoglycan binding site in the human inflammatory response protein lactoferrin, J. Biol. Chem. 269 (1994) 23661-23667.
26. H.F. Wu, D.M. Monroe, F.C. Church, Characterization of the glycosaminoglycanbinding region of lactoferrin, Arch. Biochem. Biophys. 317 (1995) 85-92.
27. D. WuDunn, P.G. Spear, Initial interaction of herpes simplex virus with cells is binding to heparan sulphate, J. Virol. 63 (1989) 52-58.
28. G. Roderiquez, T. Oravecz, M. Yanagishita, D.C. Bou-Habib, H. Mostowski, M.A. Norcross, Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41, J. Virol. 69 (1995) 2233-2239.
29. T.H.J. Matthews, C.D.G. Nair, M.K. Lawrence, D.A.J. Tyrrell, Antiviral activity in milk of possible clinical importance, Lancet 7 (1976) 1387-1389.
30. K. Hasegawa, W. Motsuchi, S. Tanaka, S. Dosako, Inhibition with lactoferrin of in vitro infection with human herpesvirus, Jpn. J. Med. Sci. Biol. 47 (1994) 73-85.
31. M.C. Harmsen, P.J. Swart, M.P. de Béthune, R. Pawels, E. De Clercq, T.H. The, D.K.F. Meijer, Antiviral effects of plasma and milk proteins: lactoferrin shows a potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro, J. Infect. Dis. 172 (1995) 380-388.
32. T. Fujihara, K. Hayashi, Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea, Arch. Virol. 140 (1995) 1469-1472.
33. M. Marchetti, C. Longhi, M.P. Conte, S. Pisani, P. Valenti, L. Seganti, Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells, Antiv. Res. 29 (1996) 221-231.
34. P.J. Swart, M.E. Kuipers, C. Smith, R. Pawels, M.P. De Béthune, E. De Clercq, D.K.F. Meijer, J.G. Huisman, Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro, AIDS Res. Hum. Retrov. 12 (1996) 769-775.
35. M.L. Groves, The isolation of a red protein from milk, J. Chem. Soc. 82 (1960) 3345-3350.
36. J.G. Sodroski, C.A. Rosen, W.A. Haseltine, Trans-acting transcriptional activation of the long terminal repeat of human T-lymphotropic viruses in infected cells, Science 225 (1984) 381-385.
37. F. Dianzani, M.R. Capobianchi, G. Antonelli, P. Amicucci, F. De Marco, Susceptibility of human immunodeficiency virus to antiviral agents measured by infectious virus yield reduction, Antivir. Res. 11 (1989) 299-306.
38. D.E. Kellog, S. Kwok, in: M.A. Innis, D.H. Gelfan, J.J. Sninsky, T.J. White (Eds.), PCR Protocols. A Guide to Methods and Applications, 1990, pp. 337-347.
39. H. Jacobsen, J. Mestan, S. Mittnacht, C.W. Dieffenbach, β-Interferon subtype 1 induction by tumour necrosis factor, Mol. Cell. Biol. 9 (1989) 3037.
40. M. Baba, P. Pauwels, L. Balzarini, J. Arnout, J. Desmyter, E. De Clercq, Mechanism of inhibitory effect of dextran sulphate and heparin on replication of human immunodeficiency virus in vitro, Proc. Natl. Acad. Sci. U.S.A. 85 (1988) 6132-6136.
41. D. Schols, R. Pauwels, J. Dsmyter, E. De Clercq, Dextran sulphate and other polyanionic anti-FHV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1, Virology 175 (1990) 556-561.
42. E.D. Weinberg, Iron withholding: a defence against viral infections, BioMetals 9 (1996) 393-399.
43. W.L. Hu, J. Mazurier, J. Montreuil, G. Spik, Isolation and partial characterization of a lactotransferrin receptor from mouse intestinal brush border, Biochemistry 29 (1990) 535-541.
44. R.D. Brines, J.H. Brock, The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron binding properties of lactoferrin in human milk and bovine colostrum. Unusual resistance of human apolactoferrin to proteolytic digestion, Biochim. Biophys. Acta 759 (1983) 229-235.
45. K. Shimizu, H. Matsuzawa, K. Okada, S. Tazume, S. Dosako, Y. Kawasky, K. Hashimoto, Y. Koga, Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity, Arch. Firol. 141 (1996) 1875-1889.
46. Y. Inouye, T. Kanamori, T. Yoshida, X. Bu, M. Shionoya, T. Koike, E. Kimura, Inhibition of human immunodeficiency virus replication by macrocyclic polyamines and their metal complexes, Biol. Pharm. Bull. 17 (1994) 243-250.